Themis Medicare Limited (NSE:THEMISMED)
104.90
-1.92 (-1.80%)
Aug 19, 2026, 3:29 PM IST
Themis Medicare Market Cap
Themis Medicare has a market cap or net worth of 9.78 billion as of August 19, 2026. Its market cap has increased by 2.13% in one year.
Market Cap
9.78B
Enterprise Value
10.69B
Revenue
3.31B
Ranking
n/a
PE Ratio
24.46
Stock Price
104.90
ChartMarket Cap Chart
Since July 26, 2001, Themis Medicare's market cap has increased from 94.35M to 9.78B, an increase of 10,261.65%. That is a compound annual growth rate of 20.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 9.78B | 5.46% |
| Dec 31, 2025 | 9.27B | -61.73% |
| Dec 31, 2024 | 24.22B | 23.62% |
| Dec 29, 2023 | 19.59B | 58.02% |
| Dec 30, 2022 | 12.40B | 42.22% |
| Dec 31, 2021 | 8.72B | 162.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 27.22B |
| Solara Active Pharma Sciences | 24.53B |
| Beta Drugs | 23.77B |
| Indoco Remedies | 20.41B |
| Sakar Healthcare | 19.88B |
| Windlas Biotech | 19.26B |
| Jagsonpal Pharmaceuticals | 15.22B |
| Sigachi Industries | 10.07B |